CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profilesPayal Jain(Children's Hospital of Philadelphia), Angela J. Waanders(Lurie Children's Hospital)OncogeneAugust 14, 201710.1038/onc.2017.276Cited by 75SaveCiteExport RISWatch citationsRelated PapersIntegrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas|Cancer Cell|2020|470MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia|Blood|2015|103HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)|Neuro-Oncology|2024|2